Dulaglutide (Trulicity) Dulaglitide is a once-weekly GLP-1 agonist that is FDA-approved for promoting glycemic control in patients with type 2 diabetes
It's also appropriate for patients who haven't achieved adequate results through lifestyle modification alone and are committed to the ongoing monitoring that a medically supervised program requires
Dutide, la nueva versin oral, ofrece una alternativa ms cmoda y accesible, que promete mejorar la calidad de vida de miles de pacientes en Argentina
Wegovy is specifically for weight loss, while Ozempic is primarily used for diabetes management, though it also aids in weight reduction
(You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online.
You get access to U.S.-based doctors